Aptevo Therapeutics Inc (APVO)

5.70 -4.31 (-43.06%) USD  |  NASDAQ  |  Dec 12, 15:28
More

Aptevo Therapeutics EV to Free Cash Flow

EV to Free Cash Flow Chart

View EV to Free Cash Flow for APVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cumulative Total Returns Versus Peers
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Free Cash Flow Range, Past 5 Years

View EV to Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Free Cash Flow Benchmarks

View EV to Free Cash Flow Benchmarks
Start Trial
Johnson & Johnson Upgrade
Merck & Co Inc Upgrade
Eyenovia Inc Upgrade
Applied Therapeutics Inc Upgrade
NovaBay Pharmaceuticals Inc Upgrade

EV to Free Cash Flow Related Metrics

EV to Revenues Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade